Edition:
United Kingdom

InVivo Therapeutics Holdings Corp (NVIV.OQ)

NVIV.OQ on NASDAQ Stock Exchange Capital Market

1.94USD
20 Sep 2018
Change (% chg)

$0.05 (+2.65%)
Prev Close
$1.89
Open
$1.94
Day's High
$1.98
Day's Low
$1.93
Volume
14,761
Avg. Vol
58,429
52-wk High
$55.00
52-wk Low
$1.64

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.00 -7.482
Mar '18 0.00 -83.463
FY 2017 Dec '17 0.00 -3.404
Sep '17 0.00 -6.989
Jun '17 0.00 -4.925
Mar '17 0.00 -4.981
FY 2016 Dec '16 0.00 -4.240
Sep '16 0.00 -4.845
Jun '16 0.00 -4.062
Mar '16 0.00 -5.877
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 1 0.00 0.00 0.00 0.00
Quarter Ending Dec-18 1 0.00 0.00 0.00 0.00
Year Ending Dec-18 1 0.00 0.00 0.00 0.00
Year Ending Dec-19 1 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Sep-18 1 -0.38 -0.38 -0.38 -3.75
Quarter Ending Dec-18 1 -0.38 -0.38 -0.38 -3.75
Year Ending Dec-18 1 -11.58 -11.58 -11.58 -16.00
Year Ending Dec-19 1 -1.11 -1.11 -1.11 -14.75
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 148.68 32.76
P/E High - Last 5 Yrs. 26.83 73.48 45.44
P/E Low - Last 5 Yrs. 26.83 21.21 24.26
Beta 3.34 0.92 0.89
Price to Sales (TTM) -- 10.42 5.75
Price to Book (MRQ) 2.80 4.10 5.00
Price to Tangible Book (MRQ) 2.80 5.02 6.57
Price to Cash Flow (TTM) -- 19.13 23.29
% Owned Institutions 18.71 25.13 2.21

Dividends

  Company industry sector
Dividend Yield -- 0.77 1.51
Dividend Yield - 5 Year Avg -- 0.72 1.52
Dividend 5 Year Growth Rate -- 8.19 5.22
Payout Ratio(TTM) -- 25.17 43.78

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 8.77 8.01
Sales (TTM) vs TTM 1 Yr. Ago -- 3.59 5.64
Sales - 5 Yr. Growth Rate -- 4.27 10.18
EPS (MRQ) vs Qtr. 1 Yr. Ago -21.24 50.66 20.61
EPS (TTM) vs TTM 1 Yr. Ago -15.83 -- --
EPS - 5 Yr. Growth Rate -- 5.27 10.66
Capital Spending - 5 Yr. Growth Rate -17.44 11.79 15.34

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.74 2.22
Current Ratio (MRQ) 5.89 2.25 3.03
LT Debt to Equity (MRQ) 3.32 40.30 12.51
Total Debt to Equity (MRQ) 5.62 49.10 16.85
Interest Coverage (TTM) -- 23.24 32.65

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 54.92 54.37
Gross Margin - 5 Yr. Avg. -- 54.68 52.17
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 16.75 10.68
Operating Margin (TTM) -- -4.59 4.32
Operating Margin - 5 Yr. Avg. -- 8.56 6.11
Pre-Tax Margin (TTM) -- -4.17 5.18
Pre-Tax Margin - 5 Yr. Avg. -- 7.67 6.51
Net Profit Margin (TTM) -- -6.34 1.48
Net Profit Margin - 5 Yr. Avg. -- 5.46 2.78
Effective Tax Rate (TTM) -- 17.39 23.11
Effective Tax Rate - 5 Yr. Avg. -- 19.85 23.97

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 14,087,940 860,372,786
Net Income/Employee (TTM) -658,405 1,184,156 101,206,913
Receivable Turnover (TTM) -- 5.26 5.87
Inventory Turnover (TTM) -- 4.97 3.41
Asset Turnover (TTM) 0.00 0.77 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -72.62 -1.15 11.13
Return on Assets - 5 Yr. Avg. -118.83 4.95 12.40
Return on Investment (TTM) -83.17 9.38 14.61
Return on Investment - 5 Yr. Avg. -273.41 6.72 16.13
Return on Equity (TTM) -86.11 14.71 16.33
Return on Equity - 5 Yr. Avg. -337.83 9.60 17.39
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 40.00 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for InVivo Therapeutics Holdings Corp

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 9.08%
# of Holders: 38
Total Shares Held: 704,725
3 Mo. Net Change: 552,155
# New Positions: 11
# Closed Positions: 22
# Increased Positions: 21
# Reduced Positions: 28
# Net Buyers: -7
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.